Table 2 Indicators for healthcare utilization
From: Cost of illness and economic burden of chronic lymphocytic leukemia
CLL group | Control group | Attributable to CLL | ||||||
|---|---|---|---|---|---|---|---|---|
Mean | STD | Mean | STD | Lower limit (2.5%) | Mean | Upper limit (97.5%) | p-Value | |
Sick leave days (paid and unpaid days) | 7.6 | (35.5) | 3.1 | (19.6) | 3.6 | 4.4 | 5.2 | <.001 (Logit) <.001 (NB)a |
Physician contacts | 14.7 | (7.5) | 9.4 | (6.6) | 5.1 | 5.3 | 5.4 | <.001b |
Inpatient stays | 0.95 | (2.10) | 0.36 | (0.96) | 0.54 | 0.59 | 0.63 | 0.007b |
Average length of stay (if hospitalized) | 9.4 | 8.8 | 0.5 | |||||
Prescriptions | 18.2 | (19.3) | 12.8 | (14.4) | 5.0 | 5.4 | 5.9 | <.001a |
Average prescription cost | 148.2 | 44.5 | 103.8 | |||||